Sujal Shah, Chief Executive Officer at CymaBay Therapeutics, Inc. (CBAY), bought 102,602 shares at $1.95 ($200K) on 2022-06-06, disclosed to the SEC on 2022-06-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.95 | 51,301 | $100K | 50.0% |
| 2 | $1.95 | 51,301 | $100K | 50.0% |
| Total | $1.95 avg | 102,602 | $200K | 100% |
| Filing → |
| CBAY | SELL | 2023-10-10 | $1.8M | — | Filing → |
| CBAY | BUY | 2019-10-15 | $22K | — | Filing → |
| CBAY | BUY | 2019-09-24 | $28K | — | Filing → |